Ioannis Kapelakis CARDIOLOGIST CLINICAL Echocardiocraphy

• Prospective study of ultrasound indicators of left ventricular systolic and diastolic function in oncology patients who receive systemic administration of Bevacizumab.

Medical school University of Athens, 2017

• Hellenic Cardiological Society
• Medical Association of Athens

• 09/2022- to date, Echocardiography department, HYGEIA Hospital.
• 2023 to date, Private Practice.
• 2020-2022 Consultant Cardiologist Intensive Care Unit (ICU), THRIASIO Hospital.
• 2018-2020 Consultant Cardiologist Medical Centre Mykonos.
• 2015-2017 Cardiologist, Bioiatriki.
• 2010-2014 Specialist Registrar in Cardiology, “EVAGGELISMOS” Hospital, Athens, Greece.
• 2007-2009 Specialist Registrar in Internal Medicine, “Oi Agioi Anargyroi” General Hospital, Athens, Greece.
• 2005-2006 Rural service. Arta’s General Hospital trimester practical education. Provincial Medical Centre Ano Kalentini and Megalochari.

Clinical Interest:

Echocardiography, Stress Echo, Transesophageal echocardiography, Athletes Heart, Cardiooncology, Heart failur

Research Interest: 

Participation in a research project of the ELKEA (Special Account for Research and Development Funds, 1^st Ministry of Health, Attica)  on the subject: A randomized double-blind study using a triple drug, which illustrates the effectiveness of otamixaban vs  unfractionated heparin + eptifibatide in patients with unstable angina or with non-ST-segment elevation myocardial infarction scheduled to coronary angiography.

• Bevacizumab increases the incidence of cardiovascular events in patients with metastatic breast or colorectal cancer.
  Ioannis Kapelakis, MD,  Konstantinos Toutouzas, MD,  Maria Drakopoulou, MD, Archontoula Michelongona, MD, Flora Zagouri, MD , Aristotle Mpamias, MD,  Paraskevi Pliatsika, MD, Meletios-Athanasios Dimopoulos, MD, Christodoulos Stefanadis,  MD, Dimitrios Tousoulis, MD.
  Hellenic Journal of Cardiology
  Volume 58, Issue 3, May–June 2017, Pages 215-219

• Cardiac Amyloidosis : Mini Review and a Case Report
  Athanasios I. Triantafyllou, Ioannis E. Kapelakis, Epameinondas A. Triantafyllou, Konstantinos M. Lampropoulos and Antonios S. Manolis
  First Cardiology Department, Evaggelismos General Hospital, Athens, Greece
  International Journal of Cardiology and Lipidology Research, 2015, 2, 14-19

• First Diagnosed Heart Failure Due to Churg-Strauss Syndrome. A Case Report
  Konstantinos M. Lampropoulos, Athanasios I. Triantafyllou, Aikaterini I. Megalou, Ioannis E. Kapelakis, Epameinondas A. Triantafyllou, Antonios S. Manolis.
  International Journal of Cardiology and Lipidology Research, 2015, 2, 16-20.

• Transesophageal Overdrive Pacing: A Simple and Versatile Tool.
  Manolis, A.S., Dragazis, I., Kapelakis, I., Papadimitriou, P., & Sakellaris, N. Hospital Chronicles, 8(3),2013.

• Echocardiography assessment of the impact of Bevacizumab on systolic and diastolic function of left ventricle in patients with metastatic cancer
  Authors: Archontoula Michelongona, Konstantinos Toutouzas, Andreas Synetos, Eleftherios Tsiamis, Ioannis Kapelakis, Flora Zagouri, Aristotle Bamias, Meletios Athanasios Dimopoulos, Stella Kyvelou, Dimitris Tousoulis, Christodoulos Stefanadis, First Department of Cardiology, Athens Medical School, Hippokration Hospital, Athens, Greece, Department of Therapeutics, Athens Medical School, Alexandra Hospital, Athens, Greece
  J Am Coll Cardiol. 2012

• The addition of Bevacizumab in the treatment of patients with metastatic cancer, increases the incidence of cardiovascular events: a prospective study
  Authors: Archontoula Michelongona, Konstantinos Toutouzas, Andreas Synetos, Flora Zagouri, Aristotle Bamias, Meletios Athanasios Dimopoulos, Stella Kyvelou, Ioannis Kapelakis, Dimitris Tousoulis, Christodoulos Stefanadis, First Department of Cardiology, Athens Medical School, Hippokration Hospital, Athens, Greece, Department of Therapeutics, Athens Medical School, Alexandra Hospital, Athens, Greece
  J Am Coll Cardiol. 2012 Mar,
• The Electrocardiogram (ECG) in the Athlete.
  Kapelakis, Ioannis, Hector Anninos, and Spyridon Koulouris. “The Electrocardiogram (ECG) in the Athlete.” Rhythmos 7.2 (2012).
• The Systemic Use of Bevacizumab Has a Direct Effect on Left Ventricular Function. A Prospective Echocardiography Study.
  Stefanadis, C., Synetos, A., Michelongona, A., Tsiamis, E., Zagouri, F., Bamias, A., Kapelakis,I… & Toutouzas, K.
  In CIRCULATION (Vol. 124, No. 21, 2011, November).

• Systemic administration of bevacizumab increases the risk of cardiovascular events in patients with metastatic cancer
  Christodoulos Stefanadis, Andreas Synetos, Dimitrios Tousoulis,Ioannis Kapelakis, Konstantinos Toutouzas.
  International Journal of Cardiology, November 11, 2011

• Antiarrhythmic drugs in patients with ICD.
  Ioannis Dragazis , Ioannis Kapelakis, Hector Anninos, Rhythmos 2010